Alumis Inc. SEC filings ALMS
Alumis Inc. has 247 filings in SEC EDGAR's recent list, going back to Feb 25, 2021. Its latest annual report, Form ARS, was filed on May 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 1, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 19, 2025 | — |
| CORRESP | Letter to the SEC | Aug 15, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 9, 2025 | — |
| 425 | Filing | Apr 29, 2025 | — |
| EFFECT | Filing | Apr 23, 2025 | — |
| CORRESP | Letter to the SEC | Apr 22, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2025 | — |
| 425 | Filing | Apr 21, 2025 | — |
| 425 | Filing | Apr 21, 2025 | — |
| 425 | Filing | Apr 21, 2025 | — |
| EFFECT | Filing | Apr 4, 2025 | — |
| 425 | Filing | Apr 4, 2025 | — |
| CORRESP | Letter to the SEC | Apr 2, 2025 | — |
| 425 | Filing | Mar 25, 2025 | — |
| 425 | Filing | Mar 19, 2025 | — |
| 425 | Filing | Mar 18, 2025 | — |
| 425 | Filing | Mar 11, 2025 | — |
| 425 | Filing | Mar 6, 2025 | — |
| 425 | Filing | Mar 4, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 19, 2025 | — |
| DRS | Filing | Feb 14, 2025 | — |
| 425 | Filing | Feb 7, 2025 | — |
| 425 | Filing | Feb 7, 2025 | — |
| 425 | Filing | Feb 6, 2025 | — |
| 425 | Filing | Feb 6, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 3, 2024 | — |
| D | Filing | Jul 24, 2024 | — |
| SEC STAFF LETTER | Filing | Jun 27, 2024 | — |
| EFFECT | Filing | Jun 27, 2024 | — |
| CERT | Filing | Jun 27, 2024 | — |
| 8-A12B | Form 8-a12b | Jun 25, 2024 | — |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| CORRESP | Letter to the SEC | Jun 18, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2024 | — |
| SEC STAFF LETTER | Filing | Jun 14, 2024 | — |
| CORRESP | Letter to the SEC | Jun 14, 2024 | — |
| CORRESP | Letter to the SEC | Jun 7, 2024 | — |
| UPLOAD | Letter from the SEC | May 30, 2024 | — |
| DRSLTR | Filing | May 15, 2024 | — |
| DRS/A | Filing | May 15, 2024 | — |
| UPLOAD | Letter from the SEC | May 8, 2024 | — |
| DRS | Filing | Apr 11, 2024 | — |
| D | Filing | Mar 11, 2024 | — |
| D | Filing | Mar 19, 2021 | — |
| D | Filing | Feb 25, 2021 | — |
Showing 46 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALMS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1847367
- Former names
- FL2021-001, Inc. (until Mar 19, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.